
The first national population-level study has shed light on the effect of the first dose of the COVID-19 vaccine. The…
The first national population-level study has shed light on the effect of the first dose of the COVID-19 vaccine. The…
Thapsigargin, a promising broad-spectrum antiviral, has proven effective for use against SARS-CoV-2, as well as the influenza A and respiratory…
Two recent papers from Public Health England (PHE; London, UK) and Rockefeller University (NY, USA) have shed new light on the duration and quality of protection provided…
Hands, face, space. These are the three tools available to everyday citizens to prevent the spread of COVID-19; the simple…
Throughout 2020, several occasions have prompted the urge to declare that “we’ve hit rock bottom. The only way is up!”…
As a new COVID-19 strain emerges in the southeast of England that appears to be more infectious than previous strains, what do…
Discover the vast impacts of the COVID-19 pandemic on the lab research community: from funding cuts, to PhD students changing…
Pfizer and BioNTech’s COVID-19 vaccine has been approved for use by the UK’s regulator, MHRA, making it the first COVID-19…
While the latest set of interim vaccine results from Oxford University and AstraZeneca include an efficacy score of 70%, significantly…
Just 1 week after Pfizer and BioNTech’s early Phase III trial data were released, more good news comes from Moderna’s…